Cassava Sciences, Inc. - Common Stock (NQ:SAVA)
All News about Cassava Sciences, Inc. - Common Stock
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data
March 25, 2025
Via GlobeNewswire
Via Benzinga
Cassava Sciences Licenses Simufilam Method of Treatment Patent
February 27, 2025
Via GlobeNewswire
Via TheNewswire.com
Via NewMediaWire
Via TheNewswire.com
Via NewMediaWire
Topics
Lawsuit
Via TheNewswire.com
Topics
Lawsuit
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.